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1.  INTRODUCTION 
 
Vaginal discharge, one of the common complaints for which women approach 
medical care is not only a source of constant distress to women but also may be  a 
sign of serious underlying infections that may result in adverse  pregnancy 
outcomes like preterm labour, premature rupture of membranes and  
chorioamnionitis and make them prone for infection with HIV and HPV.  
The prevalence of  four infections which are considered as the main causes of 
vaginal discharge namely Bacterial Vaginosis, candidiasis, trichomonas vaginalis, 
gonorrhea differ in various age groups according to the risk factors present in 
them. An insight into the distribution of these organisms in each age group, inter 
association between these infections, the risk factors and the pattern of presentation  
helps in a long way the treating clinician in the evaluation and selection of 
antibiotics and in understanding the pathogenesis of these infections. 
Various studies have shown that Colonization of vagina by microbes E.coli, 
Staphylococcus aureus and group B Streptococcus with signs of inflammation is a 
separate entity from the classical Bacterial Vaginosis where vagina is colonized by 
anaerobic microbes with absence of inflammation. This condition termed Aerobic 
vaginitis has been found to be more significantly associated with adverse 
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pregnancy outcomes than Bacterial Vaginosis.  Knowledge about the Prevalence of 
this newly defined condition in our community will help in explaining the 
symptomatic culture negative patients, treatment failures and adverse pregnancy 
outcomes. 
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2. REVIEW OF LITERATURE 
 
 The normal vagina 
 
Normal vaginal secretions are composed of vulval secretions from sebaceous 
glands, sweat glands, Bartholin glands and Skene glands, transudate from vaginal 
wall, exfoliated vaginal and cervical cells, cervical mucus, endometrial and 
oviductal fluids and micro organisms and their metabolic products. 
The type and amount of exfoliated cells, cervical mucus and upper genital 
tract fluids are determined by biochemical processes that are influenced by 
hormonal levels. Vaginal secretions may increase in the middle of the menstrual 
cycle because of an increase in the amount of cervical mucus due to estrogen. 
Normal vaginal secretions are floccular in consistency, white in colour, and usually 
located in the dependent portion of vagina- posterior fornix. 
 
The normal vaginal flora 
 
The vagina of normal asymptomatic women of reproductive age is colonized 
by multiple, aerobic or facultative bacteria as well as obligates anaerobic bacteria. 
Of this anaerobic bacteria predominate and outnumber the aerobic organisms by 
atleast in the ratio 10:1. 
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The Lower reproductive tract bacterial floras are 
 Aerobes 
 Gram positive 
o Lactobacillus species 
o Diphtheroides 
o Staphylococcus epidermidis 
o Group B streptococci 
o Enterococcus faecalis 
o Staphylococcus aureus 
o Other staphylococcus species 
 Gram negative 
o Escherichia species 
o Klebsiella species 
o Enterobacter species 
o Citrobacter species 
o Acinetobacter species 
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o Proteus species 
o Pseudomonas species 
 Anaerobes 
 Gram positive cocci 
o Peptostreptococcus species 
o Clostridium species 
 Gram positive bacilli 
o Lactobacilli species 
o Propionibacterium species 
o Eubacterium species 
o Bifido bacterium species 
 Gram negative 
o Prevotella species 
o Veilonella species 
o Bacteroides species 
 Candida albicans  
 other Candida species 
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Figure 1: Lactobacilli predominant vaginal flora 
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A study conducted on asymptomatic reproductive age women recovered a 
mean of 4.2 and 2.1 bacterial species from ectocervix and andometrial cavity. Of 
this 17% were recovered from endometrium only and 50% were recovered from 
endocervix only and the remaining was recovered from both endocervix and 
endometrium. This shows that upper reproductive tract is accessible to certain 
bacteria that are normally found in the vagina. 
 The function and reason for colonization of vagina by bacteria remains 
unknown. There are studies which show that there is a symbiotic relationship 
between the vaginal microflora and the host and this relation is alterable depending 
on the micro environment. These organisms colonize in the sites where their 
survival needs are met and these are exempted from the infection preventing 
destructive capacity of the host. 
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Defensive mechanisms in vagina 
 In this vaginal ecosystem, some microorganisms predominantly lacto 
bacilli produce lactic acid and hydrogen per oxide that prevents the 
growth of pathogenic, non indigenous micro organisms. 
 There are antibacterial compounds produced by the vaginal epithelial 
cells called bacteriocins which inhibit the growth of pathogenic micro 
organisms. Examples of bacteriocins include acidocin, lactacin. Some 
species of bacteria secrete proteinaceous adhesion molecules that 
attach them to vaginal epithelial cells.  
 For protection from various toxic substances produced by bacteria, 
vaginal epithelial cells secrete leukocyte protease inhibitory factor, 
which protects the vaginal epithelial lining from toxic inflammatory 
products and infections. 
 Vaginal pH 
Vaginal pH
   
typically ranges from 4 to 4.5. This is believed to 
result from the lactic acid and other organic acids produced by 
Lactobacilli species. In addition, amino acid fermentation by 
anaerobic bacteria and bacterial protein catabolism also helps in 
maintaining the acidity of the vaginal secretions. Nutrients for micro 
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flora in vaginal ecosystem are provided by glycogen present in the 
healthy vaginal epithelial cells. Consistent with this glycogen content 
within the epithelial cells which depends on the estrogen levels in 
body decreases in menopausal women results in decreased substrate 
for acid production. This results in rise in vaginal pH. Cailouette and 
his associates shoed in their study that vaginal pH
 
of 6 to 7.5 is 
strongly suggestive of menopause in the absence of associated 
symptoms of infection and also serum follicle stimulating hormone 
and vaginal acidity are positively correlated and there is an inverse 
relationship between the serum follicle stimulating hormone, vaginal 
acidity and the serum estradiol levels. 
 
Altered microflora 
 Changing any of these elements may alter the type of species colonizing the 
vagina. This is evident from the fact that the prevalence of Lactobacilli in the 
vagina of post menopausal women not receiving hormone replacement therapy and 
young girls is low compared to that of reproductive age women. Devillard and his 
associates in their study showed that hormone replacement therapy restored the 
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lactobacilli predominant vaginal flora which protected them against infective 
pathogens.  
 Normal vaginal flora is also altered by the menstrual cycle. These are 
transient changes, occurring predominantly in the first part of the cycle and hence 
presumed to be due to the hormonal changes. 
 There are other events that may alter the bacterial flora resulting in infection. 
These are treatment with broad spectrum antibiotics that destroys the normal 
vaginal flora and menstruation that washes out these bacteria.  Menstrual fluid can 
serve as a source of nutrients for many bacterial species that will result in their 
overgrowth. Hysterectomy where cervix is removed results in the change of 
microbial flora of the lower reproductive tract with or without antibiotic therapy. 
There is an increase in the concentration of anaerobic species in the vagina post 
operatively with a particular increase in the concentration of Bacteroides fragilis. 
There is also an increase in the concentration of Escherichia and Enterobacter 
species. These are the three species which are frequently cultured from vagina of 
patients with post operative pelvic infections. 
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Examination of vaginal secretions 
 
 Wet mount preparation 
 
A sample of vaginal secretions is suspended in 0.5ml of normal saline in a 
tube, transferred to a slide, covered with a slide, and assessed by microscopy. 
Slides can also be prepared by suspending secretions in saline placed directly on 
the slide. Microscopy of normal vaginal secretions reveals many superficial 
epithelial cells, few white blood cells (less than 1 per epithelial cell), and few, if 
any clue cells. Clue cells are superficial vaginal epithelial cells with adherent 
bacteria, usually Gardnerella vaginalis, which obliterates the crisp cell border when 
visualized microscopically. 
 
 Potassium hydroxide preparation 
 
Few drops of 10% potassium hydroxide are added to the slide to examine the 
secretions for evidence of fungal elements. In case of Bacterial Vaginosis, addition 
of KOH results in the release of amines that have characteristic fishy odour which 
helps in the diagnosis of the condition. 
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Gram staining 
 
Smear made with vaginal secretions placed on a slide. After heat fixing the 
smear,  flood slide with crystal violet, rinse the excess agent with tap water, flood 
the slide with iodine, rinse the excess iodine with tap water, decolourise using 
alcohol / acetone, flood the slide with carbol fuchsin, rinse excess reagent, air dry 
the smear and examine the slide under microscope.   
Neisseria gonorrhoeae - typical intracellular gram negative diplococci 
Candida albicans - gram positive budding yeast cells with pseudo hyphae 
 
 Culture 
 
Neisseria gonorrhoeae - McLeod’s chocolate agar medium 
E.coli, Staphylococcus aureus, Streptococci- blood agar medium 
Candida albicans- sabourauds agar medium 
 
 Bacterial vaginosis 
 
It is an alteration in normal vaginal bacteria that results in the loss of 
hydrogen peroxide producing lactobacilli and an overgrowth of predominantly 
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anaerobic bacteria that includes Gardnerella vaginalis, Ureaplasma urealyticum, 
Moniluncus species, Mycoplasma hominis, and Prevotella species. In normal 
women anaerobic bacteria can be found less than 1% of normal flora. In women 
with Bacterial Vaginosis, however the concentration of anaerobes gardnerella 
vaginalis and mycoplasma hominis is 100 to 1000 times higher than in normal 
women. Lactobacilli are usually absent. Whether an alteration in the ecosystem 
leads to lactobacilli disappearance or its disappearance results in the changes 
observed in lactobacilli is not known.  
This has been variously termed and the older terms include Haemophilus 
vaginitis, Corynebacterium vaginitis, Gardnerella vaginitis, anaerobic vaginitis and 
non specific vaginitis. 
 
 Predisposing factors 
 
This condition is not considered by the Centre for Disease Control and prevention 
as a sexually transmitted disease and it has been seen in women without sexual 
exposure. However many risk factors are associated with sexual activity and 
increased incidence of sexually transmitted diseases is seen in women affected 
with Bacterial Vaginosis. 
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 Repeated alkalinisation of vagina which occurs with frequent sexual 
intercourse 
 Oral sex 
 Black race 
 Cigarette smoking 
 Washing out by menstrual blood 
 Use of douches 
 Use of IUCD 
 
 Clinical features 
 
The patients present with a homogenous, white, non viscous, malodourous 
uniformly adherent vaginal discharge. The discharge may be profuse enough to be 
seen at the labia. When other infections like trichomonas and candida are 
associated which they most often the picture may be modified.  
 
 Complications 
 
Numerous studies show an association of Bacterial Vaginosis with 
significant adverse sequelae. Women with Bacterial Vaginosis are at increased risk 
for  
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 pelvic inflammatory disease 
 post abortal PID 
 post hysterectomy cuff infections 
 abnormal cervical cytology 
 premature rupture of membranes 
 preterm labour 
 chorioamnionitis 
 post caesarean endometritis 
 
 Diagnosis 
 
Diagnosis of Bacterial Vaginosis can be achieved by simple lab procedures 
combination of clinical examination and simple lab procedures.  
 
Amsel Criteria 
Diagnosis of bacterial vaginosis is made when three of the following four 
criteria are satisfied. . 
 Vaginal discharge 
 pH of the secretion higher than 4.5 
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 Microscopy revealing increased number of clue cells and leukocytes are 
conspicuously absent. Clue cells are vaginal epithelial cells whose borders 
appear obscured by the numerous Gardnerella bacilli that are adherent to the 
epithelial cell wall. 
 Addition of KOH to the vaginal secretions releases fishy odour due to the 
release of amines. 
 
Nugent scoring 
This is based on gram staining of the vaginal secretions of the patient. Number 
of organisms visualized per high power field in microscope after gram staining 
the vaginal smear. The advantage of this scoring system is it has low inter-
observer variability and high reproductivity. Hence it is mostly used for 
research purposes.  
Lactobacilli morphotype - large gram positive rods 
Gardnerella morphotype - small gram negative or gram variable rods 
Mobiluncus morphotype – curved gram negative to gram variable rods 
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Nugent score 
Lactobacilli 
morphotype per 
field 
Gardnerella 
morphotype per 
field 
Mobiluncus 
morphotype per 
field 
0 > 30 0 0 
1 5 to 30 < 1 1 to 5 
2 1 to 4 1 to 4 > 5 
3 < 1 5 to 30  
4 0 > 30  
Table 1: Nugent Scoring 
 
Here N score = the sum of the scores for each bacterial morphocyte listed 
above. 
If N score is Clue cells Report 
0 to 3  
Not consistent with Bacterial 
Vaginosis 
4 to 6 Absent 
Not consistent with Bacterial 
Vaginosis 
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4 to 6 Present Consistent with Bacterial Vaginosis 
> 7  Consistent with Bacterial Vaginosis 
Table 2: Interpretation of Nugent Scoring 
 
Hay / Ison criteria 
 Grade 1 – lactobacilli predominate 
 Grade 2 – mixed flora with lactobacilli and Gardnerella and mobiluncus                  
morphocytes also present 
 Grade 3 – predominantly Gardnerella or Mobiluncus morphocyte seen. 
Few or absent lactobacilli. 
 
Culture 
Culture is not a diagnostic method for Bacterial Vaginosis as micro organisms 
associated with Bacterial Vaginosis namely Gardnerella vaginalis; Mobiluncus 
can also be cultured from normal vagina. 
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Figure 2: Vaginal epithelial cells studded with anaerobic bacilli – clue cell seen in wet mount 
preparation 
 
 
 
Treatment  
Ideally, treatment of Bacterial Vaginosis should inhibit anaerobes but not 
vaginal lactobacilli. The following treatments are effective: 
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 Metronidazole 
An antibiotic with excellent activity against anaerobes but poor 
activity against lactobacilli is the drug of choice for the treatment of 
Bacterial Vaginosis 
Dosage: orally, 500mg administered twice daily for 7 days. 
Metronidazole gel 0.75%, one applicator intravaginally, once daily for 
five days may also be prescribed. 
The overall cure rate ranges from 75% to 84% with the 
aforementioned regimens. 
 Clindamycin 
Clindamycin in the following regimens is effective in treating 
Bacterial Vaginosis. 
1. Clindamycin ovules, 100mg, intra vaginally once at bedtime for 3 
days. 
2. Clindamycin bioadhesive cream, 2% 100 mg intravaginally in a 
single dose. 
3. Clindamycin cream, 2% one applicator full intravaginally at 
bedtime for 7 days. 
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4. Clindamycin, 300 mg, orally twice daily for 7 days. 
Intravaginal treatment is preferred to avoid systemic side effects such as 
mild to moderate gastrointestinal upset and unpleasant taste. 
Treatment of the male sexual partner does not improve therapeutic response 
and therefore is not recommended. 
 
Role of probiotics 
 
Studies have shown that probiotics are highly effective given alone or in 
combination with antibiotics. They can be given orally or intravaginally. 
Studies have also shown that use of probiotics can be effective in the 
prevention of recurrences. One study has shown that topical application of the 
probiotic once a week for 6 months is effective in almost complete prevention of 
recurrence in the study group and is still effective for 12 months. Cochrane review 
in 2009 is neutral about the use of probiotics in the treatment of Bacterial 
Vaginosis. 
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 Candidal vaginitis 
 
An estimated 75% of women experience atleast one episode of vulvovaginal 
candidiasis during their lifetimes. 
Candida albicans is responsible for 85% to 90% of vaginal infections. Other 
species of candida such as C.glabrata and C.tropicalis can cause vulvovaginal 
symptoms and tend to be resistant to therapy. 
Candida are dimorphic fungi existing as blastospores, which are responsible 
for transmission and asymptomatic colonization and as mycelia, which result from 
blastospore germination and enhance colonization and facilitate tissue invasion. 
 
 Pathogenesis 
The extensive areas of pruritus and inflammation often associated with 
minimal invasion of the lower genital tract epithelial cells suggest that an 
extracellular toxin or enzyme may play a role in the pathogenesis of the disease.   
A hypersensitivity phenomenon may be responsible for the irritative 
symptoms. 
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Patients with symptomatic disease usually have an increased concentration 
of these micro-organisms (>10
4
 per ml) compared with asymptomatic infections 
(10
3
 per ml). 
 
 Predisposing factors 
 
 Antibiotic use 
 pregnancy 
 diabetes 
Pregnancy and diabetes are associated with a qualitative decrease in cell 
mediated immunity, leading to a higher incidence of candidiasis. 
 
Clinical features 
 
The symptoms consist of vulval pruritus associated with a vaginal discharge 
that typically resemblance cottage cheese. The discharge can vary watery to 
homogeneously thick.  
Vaginal soreness, dyspareunia, vulval burning and irritation may be present. 
External dysuria (splash dysuria) when micturition leads to exposure of 
inflammed vulval and vestibular epithelium to urine. 
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Examination reveals erythema and edema of the labia and vulval skin. 
Discrete pustulopapular peripheral lesions may be present. The vagina may be 
erythematous with adherent white discharge. The cervix appears normal. 
 
 Diagnosis 
 
 KOH preparation shows budding yeast cells with pseudohyphae. 
 Saline preparation usually is normal although there may be a slight increase 
in the inflammatory cells in severe cases. 
 The pH of the vagina in patients is usually normal(<4.5) 
 The whiff test is negative 
A presumptive diagnosis is made in the absence of fungal elements 
confirmed by microscopy if the pH and the results of saline preparation evaluation 
are normal and the patient has increased erythema based on examination of vulva 
and vagina. 
 A fungal culture is recommended to confirm the diagnosis.  
Conversely, women with a normal physical examination findings and no 
evidence of fungal elements disclosed by microscopy are unlikely to have 
vulvovaginal candidiasis and should not be empirically treated unless a vaginal 
yeast culture is positive. 
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Figure 3: Pseudo-hyphae with budding yeast cells seen in KOH preparation 
 
 
 Treatment 
 
Topically applied azole drugs are the most commonly available treatment for 
vulvovaginal candidiasis. Treatment with azoles results in relief of symptoms and 
negative cultures in 80%to 90% of patients who have completed therapy. 
Symptoms usually resolve in 2 to 3 days. Short course regimens upto 3 days is 
effective. Although the shorter period of therapy implies a shortened duration of 
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treatment, the short course formulations have higher concentrations of the 
antifungal agent, causing an inhibitory concentration in the vagina that persists for 
several days. 
The oral antifungal agent, fluconazole used in a single 150mg dose is 
recommended for the vaginal candidiasis. It appears to have equal efficacy when 
compared with topical azoles in the treatment of mild to moderate vaginal 
candidiasis. Patients should be explained that their symptoms will persist for 2 to 3 
days so they will not expect additional treatment. 
Women with complicated vaginal candidiasis benefit from an additional 150 
mg dose of fluconazole given 72 hours after the first dose. Patients with 
complications can be treated with a more prolonged topical regimen lasting 10 to 
14 days. Adjuvant treatment with a weak topical steroid such as 1% hydrocortisone 
cream may be helpful in relieving some of the external irritative symptoms. 
 
Other Candidal species 
Vaginitis has been also reported to be caused by other species of Candida 
like Candida glabrata, Candida tropicalis. These species are responsible drug 
resistant infections. 
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Trichomonas vaginitis 
Trichomonas Vaginitis is caused by the sexually transmitted, flagellated 
parasite, Trichomonas vaginalis. The transmission rate is high; 70% of men 
contract the disease after a single exposure to an infected woman, which suggests 
that the rate of male to female transmission is even higher.  
 
 Pathogenesis 
 
Trichomonas vaginalis is an ovoid motile flagellated parasite 15 to 20 
micrometer in length and 8 to 10 micrometer in width although smaller forms are 
described. It has four anterior flagella and an axostyle which traverses its body to 
end in a spike. 
The infection is essentially of the vaginal epithelium and the parasite shelter 
between the rugae. It is possible that they may penetrate between the surface cells 
but no deeper and they induce usual inflammatory reaction. 
In 70 to 80 % of cases the trichomonads can also be cultured from the 
urethra, where they cause acute or chronic urethritis. Bartholin’s glands and 
Skene’s tubules are sometimes infected. 
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There are reliable reports of the organisms having been found in the cervix, 
body of uterus, the fallopian tubes and even in the blood stream but their 
significance in these sites is questionable. 
 
Clinical features 
 
The first symptom is usually sudden onset of purulent vaginal discharge 
often dating from menstruation. It is said to be cream colored and frothy but its 
physical characteristics vary widely. It may be profuse or scanty. 
The most constant feature is that it causes pruritus, the itching being felt 
around and within the introitus. 
At the outset dysuria and frequency of urine are also common complaints. 
Vaginal tenderness and congestion result in dyspareunia. 
On examination, 
 In acute stage the labia minora and introitus are sometimes 
edematous. 
 The vagina may be diffusely fiery red in colour but often presents a 
strawberry appearance which, on cervix can be confused with erosion. 
 The external urethral meatus is congested and pouting. 
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 Later or when the reactions are less severe the disease is manifested 
by a granular appearance which is most obvious in the fornices, on the 
portio vaginalis, and around the urethral orifice. 
The infection can become very chronic with pruritus more prominent than 
discharge, and is subject to periodic exacerbations over the course of many years. 
The same is true for urethritis. So recurrent cystitis in women is very often 
explained by flare ups of a persistent Trichomonas urethritis. 
 
 Diagnosis 
 
Wet smear can be made in the office. Specimens, uncontaminated by 
lubricant are taken from the vagina by a swab or pipette and examined 
microscopically. For this purpose the material is mixed with saline solution on a 
warm slide, covered with a glass slip and left unstained. The trichomonads are 
recognized by their shape, size, - larger than a pus cell but less than half the size of 
a vaginal squame.  
 
 Culture 
Culture methods are more accurate. The specimen of discharge or preferably 
the whole cotton tip of the swab is added immediately to a small tube of 
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Kupferberg’s medium or Feinberg-Whittington medium. The latter is a proteolised 
liver and inactivated horse serum preparation with streptomycin and penicillin 
added. It eliminates all organisms except Trichomonas and candida. Incubation 
preferably at 34degree rather than 37 degree is followed by examination of drops 
of fluid for organism at 24 and 48 hours and if needed later. It is the only method 
reliable in males. 
The finding of Trichomonas indicates a need to exclude gonorrhea as well. 
Candida and Trichomonas infestations also commonly coexist but the dual nature 
of the infection is not always evident until the dominant organism – Trichomonas 
is eliminated. The persistence of symptoms after with Trichomonacides therefore 
calls for repeated cultures for both Candida and gonococci. 
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Figure 4: Flagellated Trichomonas organism with leukocyte infiltration seen in wet 
mount preparation 
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Treatment 
 
Metronidazole is the drug of choice for treatment of vaginal trichomoniasis. 
Both a single dose 2gm orally and a multi dose 500mg twice daily for 7 days 
regimens are highly effective and have cure rates of about 95% 
Women who do not respond to initial therapy should be treated again with 
500mg twice daily for 7 days. If repeated treatment is not effective the patient 
should be treated with a single 2g dose of metronidazole once daily for 5 days or 
tinidazole 2gm in a single dose for 5 days. 
In patients who do not respond to repeated treatment with metronidazole and 
tinidazole culture of the parasite has to be done to identify the sensitivity of the 
organism.  
 Treatment of sexual partner is mandatory in case of infection with 
Trichomonas vaginalis failing which recurrences are common. 
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Gonorrhoea  
Gonorrhea is an infection caused by a gram negative diplococcus – Neisseria 
gonorrhoeae and in the adult women contracted by sexual contact. Transfer 
through other means is a theoretical possibility except in babies whom can be 
infected in their passage through the vaginal canal which will result in ophthalmia 
neonatorum. 
 
 Pathogenesis 
The bacteria first attack those tissues of the lower genital tract which are not 
covered by squamous epithelium- the endocervix, the urethra including 
paraurethral tubules, the ducts and acini if bartholins glands. Gonococci also 
spread commonly to anorectum which are implanted there during anal coitus. 
Generally, the infection remains confined to lower genital tract but in 10% 
of proven cases of gonorrhea it spreads upwards to cause salpingo oophoritis of 
varying degree. The organisms ascend through the uterus to the tubes producing a 
fleeting acute endometritis on the way which is clinically not evident being 
overshadowed by the symptoms of salpingitis. Both tubes are always involved and 
the essential lesion is endosalpingitis. The organisms spread via the abdominal 
ostia to produce pelvic peritonitis and salpingitis. Generalized peritonitis is rare.  
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The most important and tragic sequel to gonorrhea is tubal damage and closure 
which will threaten future reproduction. 
 
 Chronic infection 
 
No matter whether it has a dramatic or quiet onset, gonorrhoea persists as a 
chronic but contagious disease for many years. The organisms linger in 
endocervix, bartholins glands, periurethral tubules and rectum but give rise to no 
symptoms or at most to a slight degree of chronic mucopurulent vaginal discharge. 
 
 Diagnosis 
 
In the classical case, the diagnosis of gonorrhea is usually suggested by the 
history of exposure, the acuteness of the onset of a purulent discharge, the 
associated urethritis, and the appearance of zones of congestion (maculae) around 
the orifices of Bartholin’s ducts.  In practice, it is the occurrence of urethritis in the 
patient’s consort which often brings the woman to investigation, she herself having 
no symptoms. 
 Sixty percent of women with proven gonorrhea also suffer from 
Trichomonas vaginalis and/or Chlamydia trachomatis.  Candida albicans, herpes 
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simplex virus, etc. are also associated.  So the disease should be suspected 
whenever there is a complaint of vaginal discharge. 
 The diagnosis can only be proved by the demonstration of gonococci in the 
genital tract secretions or in the lower rectum.  In the female it is rare to find 
typical Gram-negative intracellular diplococcic in direct smears of vaginal 
discharge, unless a very acute infection is present.  The setting up of cultures is 
therefore mandatory and material for these is obtained from the endocervical canal.  
Cultures of the urethra, anal canal and pharynx are recommended, but produce 
only a slight increase in the yield.  When gonococcal septicaemia, pharyngitis or 
arthritis is suspected, it is necessary also to prepare cultures from blood, throat 
swabs and synovial fluid.  Gonococci will survive on ordinary swabs for 
approximately 2 hours.  A longer interval than this between the collection of 
specimens and their arrival in the laboratory means the use of transport media such 
as Stuart’s agar and crystal violet, or one of the proprietary preparations in the 
market.  Alternatively, plates of warmed chocolate agar or of Thayer – Martin 
medium can be inoculated directly by the patient’s bedside. 
 The woman should not have passed urine or used a douche before 
examination.  Having wiped its orifice clean, the urethra is milked to obtain 
discharge from the paraurethral glands.  Further material is obtained by milking 
Bartholin’s glands and their ducts.  Swabs are next taken from the endocervix and 
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finally from the anal canal and rectum.  In proven cases of gonorrhea, the 
organisms are found in Bartholin’s ducts in 30 percent, in the endocervix in 90 
percent and in the rectum in 50-60 percent.  The last two are therefore the most 
important sites to study and it is stated that a combination of their findings 
provides an almost 100 percent accurate diagnostic test. 
 Nevertheless, negative findings, even when repeated, are never conclusive 
and it is impossible to be certain that a woman does not have gonorrhoea. 
 Similarly, tests of cure are unsatisfactory although negative bacteriological 
findings on three occasions are the accepted criteria.  The best time to perform 
these is immediately after menstruation.  Enzyme-linked immunosorbent assay 
(ELISA) tests have been developed which offer greater reliability. 
 Whenever gonorrhoea is diagnosed or suspected, it is essential to entertain 
the possibility of the patient having contracted syphilis at the same time.  The case 
must therefore also be investigated from this stand-point and, meanwhile, no 
treatment given which might mask, without curing, the disease. 
 Antibiotic sensitivity of the organism is becoming important because of the 
resistant or less sensitive strains.  The detection of penicillinase-producing strains 
of N.gonorrhoea which are totally resistant to penicillin and relatively insensitive 
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to several other antibiotics is important as these strains are spreading throughout 
the world. 
 
 
Figure 5: Gram stain showing intra-cellular gram negative diplococci 
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Treatment 
 If there is a severe systemic reaction, or if acute salpingitis is present, the 
patient should be put completely at rest in hospital and given intensive antibiotic 
therapy in divided doses.  Otherwise she can remain ambulant but should be 
warned against coitus until pronounced cured.  Except for the drainage of an 
abscess, local treatment should be avoided lest it encourage the spread of infection. 
 Penicillin used to be remedy of choice in gonorrhoea.  A single 
intramuscular injection of 4.8 mega units of procaine penicillin can be curative but 
the emergence of penicillinase-producing strains of N.gonorrohoea led to the use 
of other agents.  Further, some authorities felt that this dosage was inadequate in 
case of concomitant syphilis.  Although, in general, this is very rare nowadays, 
there may be some settings where this is relevant. 
 Several of the newer quinolones, e.g. ciprofloxacin and ofloxacin have been 
used successfully as single-dose regimens, 500mg and 400mg, respectively.  
Quinolone resistant strains have emerged in some Pacific and Asian countries, but 
CDC continues to recommend these in areas where there is no problem of 
resistance.  However, quinolones should not be used in pregnant women. 
 Ceftriaxone is recommended by CDC for the treatment of uncomplicated 
gonorrhoea in a single intramuscular injection of 125mg.  It cures rectal and 
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pharyngeal gonorrhoea as well.  Some patients allergic to beta-lactam antibiotics 
may show reaction - cefixime is a useful oral alternative.  Spectinomycin, 4g in a 
single intramuscular injection, is useful in treating anogenital gonorrhoea but does 
not treat pharyngeal gonorrhoea. 
 
 Aerobic vaginitis 
Vaginal microflora which is a complicated environment is made of varying 
organisms in varying proportions. Whereas the diagnosis of Bacterial Vaginosis is 
straight forward with Amsels criteria or Nugents scoring with gram staining as is 
the normal lactobacilli dominant vaginal flora, there is also another type of 
abnormal flora that could neither be called Bacterial Vaginosis nor as normal. 
Studies have shown that this type of flora termed Aerobic vaginitis is more closely 
associated with adverse pregnancy outcomes and is different from Bacterial 
Vaginosis in aetiology, pathogenesis, clinical presentation and treatment. 
 
 Aetiology 
 
Replacement of normal hydrogen peroxide producing lactobacilli by aerobic 
bacteria like E.coli, Staphylococcus aureus, group B Streptococcus results in 
Aerobic Vaginitis. Measurement of lactic acid in vaginal secretions is low in both 
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Bacterial Vaginosis and Aerobic Vaginitis due to absence of lactobacilli but the 
levels of succinate in vaginal secretions is high in Bacterial Vaginosis as it is 
produced by gardnerella vaginalis and not by aerobic organisms causing Aerobic 
Vaginitis. 
 
 Pathogenesis 
Whereas wet mount preparation in Bacterial Vaginosis is by absence of 
signs of inflammation with no leukocyte infiltration, in Aerobic Vaginitis, there is 
leukocyte infiltration. This is also evident from the high concentration of 
inflammatory markers like IL1, IL6, and leukemia inhibitory factor in vaginal 
secretions of patients with the diagnosis of Aerobic Vaginitis than in patients with 
Bacterial Vaginosis. 
 
 Clinical features 
 
 Patient presents with yellowish discharge. 
 An offensive odour is usually present not fishy odour but more of a foul 
smelling rotten odour. Itching is rare.  
 On examination vagina will appear red and inflamed, may even show small 
to large ulcerations 
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Diagnosis 
 
Aerobic vaginitis can be diagnosed from microscopic examination. 
 
AV 
score 
LBG No of leukocytes 
Proportion of 
leukocytes 
Background flora 
Proportion 
of PBC 
0 
I and 
IIa 
≤10/ hpf 
None or 
sporadic 
Unremarkable or 
cytolysis 
None or < 
1% 
1 IIb 
>10/hpf and ≤ 
10/epithelial cell 
≤ 50% of 
leukocytes 
Small coliform 
bacilli 
≤ 10% 
2 III > 10/epithelial cell 
> 50% of 
leukocytes 
Cocci or chains >10% 
 
Table 3: Aerobic Vaginitis scoring 
 
I - normal lactobacilli predominant slide 
IIa - mixed infection with lactobacilli as prominent flora 
IIb - mixed infection with decreased lactobacilli 
IIIc - mixed infection with no lactobacilli 
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Aerobic vaginitis scoring  
0 to 3 – no sign of Aerobic Vaginitis 
3 to 4 – minimal Aerobic Vaginitis 
5 to 6 – moderate Aerobic Vaginitis 
>6 – severe Aerobic Vaginitis 
 
 Treatment 
 
 Topical kanamycin has been advocated as the treatment for Aerobic 
Vaginitis 
 Topical clindamycin can also be used 
 Metronidazole is not useful in contrast to Bacterial Vaginosis for which drug 
of choice is metronidazole. 
 
Purulent vaginitis 
Also called streptococcal vaginitis 
Can be considered as the extreme form of Aerobic Vaginitis 
Caused by Group B Streptococci 
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Cytolytic vaginosis 
This is a clinical condition where lactobacilli become invasive and invades 
the vagina resulting in inflammation. 
Cause of this condition is yet to be defined. 
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Kulkarni et al
1
 did a study involving 506 females in Nagpur. Prevalence of white 
discharge in them was 27.47% (139).  35.29% of patients with complaints were 
married. It also studied the effect of low socio economic condition. 
Desai et al
2
, in their study found that 31% of females participated in their study had 
complaints of white discharge. 
Parashari et al
3
 in their study found that prevalence of white discharge to be 70.1%.   
Of this, the married population was 35.29%. 
Snehalatha Vishwanath et al
4
, in their study involving 319 women, Bacterial 
Vaginosis is more common with prevalence around 26% prevalence of Chlamydia 
12.2%, Trichomonas 10%, no gonorrhoea isolated. 
Vikram Patel et al
5
 in his study involving 2494 women, only 14.5% had abnormal 
white discharge. Somatoform disorders and IUCD use are positively associated 
with infection and low literacy and age more than 40 years are negatively 
associated with infections. 
Kaven Trollope Kumar in their study found that only 30% of women with 
complaints of white discharge are positive for infections in south Asian population. 
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International family planning perspectives in their study Found that 38% of 
patients with white discharge had infections.53% of these patients had associated 
gynecologic symptoms.  
RD Caterall et al
6
 in his study on Diagnosis of vaginal discharge, of the 300 
women included in the study, Trichomonas Vaginitis was found to be the most 
common cause-41.6%. Prevalence of candidal infection is 34%, of gonococci 
31.6%, 4 cases of senile vaginitis in postmenopausal women studied. There were 3 
cases of non invasive cervical cancer, 2 cases of invasive cervical cancer, 6 cases 
of benign cervical polyp, 8 cases of foreign body which could be forgotten 
tampons or IUCDs. 
Pierce AM et al
7
 in their study stated that major causes of vaginal discharge in 
prepubertal and pubertal age group are poor hygiene, thread worm infestation, 
sexual abuse and dermatologic conditions. 
Arsenio Spinillo et al
8
 in their study on the relationship vaginal infections between 
reproductive age group and post menopausal group found that incidence of candida 
and Trichomonas in reproductive age group are 34.1% and 1.92% respectively and 
that of postmenopausal women are 3.5% and 10.8% respectively. Prevalence of 
Bacterial Vaginosis is common in both groups. 30% of postmenopausal patients 
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with complaints of white discharge were positive for infections. Other causes seen 
were estrogen deficiency, local irritants, allergens, dermatologic conditions. 
Mirza NB et al
9
 in their study on microbiology of vaginal discharge found that 
prevalence of Gonorrhoea – 26%; Trichomonas Vaginitis – 34%; Candida – 24%; 
Bacterial Vaginosis – 25% and mixed infections of atleast two organisms are seen 
in 23% of patients. 
Faye-kette-YH
10
 et al in their study on 6603 women with white discharge found 
that prevalence of Candida albicans to be 25%; Bacterial Vaginosis – 17.4%; 
Trichomonas Vaginitis – 8.2% and Gonorrhoea – 3.2% 
Abauleth et al
11
 in their 7 month prospective descriptive study from October 2003 
to 2004 found that the prevalence of individual organisms to be Bacterial 
Vaginosis – 47%; Candida – 29.4%; Trichomonas Vaginitis – 6.9%; Gonorrhoea – 
2.9% 
Lobb Phillipon M et al
12
 in their survey on 579 patients with white discharge, the 
prevalence was found to be Gonorrhoea – 64.4%; Bacterial Vaginosis – 24%; 
Candida – 20%; Trichomonas Vaginitis – 14% 
Santhosh Chaturvedi et al
13
 in his study on psycho somatic syndrome, 40% of 
patients with psycho somatic symptoms had white discharge and they attributed 
their illness to abnormal white discharge PV. 
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 Donders et al
14
 in his study in 2003 on 631 women with white discharge proved 
that there is a separate entity from Bacterial Vaginosis that differs from Bacterial 
Vaginosis in aetiology, pathogenesis, clinical presentation and treatment. This 
study also showed that this condition termed Aerobic Vaginitis can result in 
adverse pregnancy sequel compared to Bacterial Vaginosis due to associated 
inflammation in this condition which is conspicuously absent in patients with 
Bacterial Vaginosis. 
Donders et al
15
 in 2009, in another study showed that abnormal vaginal flora 
characterized by colonization by aerobic bacteria like E.coli, Staphylococcus 
aureus, group B streptococci with associated signs of inflammation proved by 
increased concentration of inflammatory cytokines in vaginal secretions and 
leukocyte infiltration on microscopy before 14 weeks of gestation is a risk factor 
for preterm labour and delivery and prophylactic antibiotics in such patients may 
aid in preventing this adverse pregnancy outcome. 
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3.  AIM 
 
To analyse the epidemiological pattern of infectious causes of abnormal 
white discharge and to identify the prevalence, patient characteristics, pattern of 
presentation, risk factors for the newer condition Aerobic Vaginitis in our 
community. 
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4. MATERIALS AND METHODS 
 
Study design 
 
 Cross-sectional Analytical study 
Period of study 
 September 2012 to September 2013  
Place of study 
 Gynaecology outpatient department, Kilpauk medical college 
hospital 
 Inclusion criteria 
 
 Women attending gynaecology OP with complaints of abnormal vaginal 
discharge from September 2012 to September 2013 without the below mentioned 
criteria for exclusion. 
 Exclusion criteria 
 
 Cervicitis/cervical dysplasia/cervical neoplasia 
 Endometrial/cervical polyp 
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 H/O recent obstetric/gynaec intervention 
 Pregnancy 
Sample size 
 
The sample size was calculated using the formula, 
 
   
               
   
 
Z - Constant (1.96). 
P - Prevalence (18%). 
d - Desired precision (0.05). 
By using this formula, n comes to 226 and the sample size for my study is 232. 
 Method 
 
 Of all women attending gynaec OP with complaints of white discharge per 
vaginum from September 2012 to September 2013, 232 were randomly selected 
for study after getting written consent. 
Detailed history comprising age of the patient, marital status, menstrual 
history, parity, and history of any recent obstetric or gynaec intervention, h/o 
diabetes elicited. 
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Patients subjected to clinical examination that includes per abdomen 
examination, local examination of external genitalia. 
Vaginal discharge collected with cotton swabs subjected to microscopic 
examination with KOH and on wet mount, gram staining, pH analysis, and whiff 
test. 
Diagnosis of Bacterial Vaginosis, candidal vaginitis, vaginitis due to 
trichomonas vaginalis, gonorrhea and Aerobic Vaginitis were made by following 
definitions. 
 Bacterial vaginosis 
 
When 3 out of 4 of Amsel criteria are present  
 Vaginal discharge 
 Elevated pH > 4.5 
 Clue cells on wet mount preparation 
 Fishy odour on adding 10% KOH solution 
 Vaginal candidiasis 
 
  Fungal culture with Sabouraud’s agar medium 
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 Trichomonas Vaginitis 
 
  Presence of flagellated motile organism with wet mount preparation 
 Gonococcal infection 
 
  Positive culture on McLeod’s chocolate agar medium 
 Aerobic vaginitis 
 
Culture positive for E.coli, group B streptococci, Staphylococcus,     
Aerobic Vaginitis scoring > 3 
 Analysis 
 
Women were divided into six age groups  
 Group 1 - 10 to 19 
 Group 2 - 20 to 29 
 Group 3 - 30 to 39 
 Group 4 - 40 to 49 
 Group 5 - 50to 59 
 Group 6 - 60 to 69 
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Women were divided into four categories as on the basis of menstrual status  
1. Pubertal age category- attained menarche, below 18 years and not 
sexually active. 
2. Sexually active women in reproductive age category- 18 to 35 years 
  3. Perimenopausal age category – 45 to 52 years 
4. Postmenopausal age category – one year after the cessation of 
menses. 
The distribution of organism positive smears studied in each group and the 
prevalence of each type of infection and prevalence of mixed infections in those 
groups studied. 
Characteristics of the patients marital status, presence of pruritus, UTI 
symptoms namely increased frequency, painful micturition, H/O diabetes mellitus 
(DM) studied as prevalence in smear positive patients, percentage of symptom 
positive patients in each organism group and their significance to identify if pattern 
of presentation can aid in deciding further evaluation and treatment of the patient. 
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The prevalence of the newer entity Aerobic Vaginitis in our population is 
also studied. Patient characteristics in Aerobic Vaginitis group which may help in 
understanding the pattern of presentation and risk factors of this newer diagnosis in 
our community is also studied. 
Statistical analysis is done by chi square test for discrete variables in the 
study.  
P value less than 0.05 is considered statistically significant. 
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5. RESULTS OF THE STUDY 
 
Of the 232 patients who attended gynaec OP with complaints of white 
discharge, 128 patients (55.1%) had their smears positive for the infections studied. 
Age Distribution 
 
Table 4 - Age distribution of symptomatic and infection positive cases 
Age Group Number of 
Patients in the 
Age Group 
Percentage of 
Patients in the 
Age Group 
Smear positive  
Patients in the 
Age Group 
Percentage of smear 
positive patients in 
the Age Group 
10-19 20 8.6 % 6 30 % 
20-29 83 35.8 % 49 59 % 
30-39 12 5.2 % 9 75 % 
40-49 51 22 % 28 54.9 % 
50-59 37 15.9 % 19 51.4 % 
60-69 29 12.5 % 17 58.6 % 
 Total 232  128  
 
Inference 
 Of the patients coming with complaints of white discharge in our OP, 35.8% 
belonged to age group 20 to 29. 
 Least prevalence is seen in age group 30 to 39, followed by age group 10 to 
19. 
 75% of patients with white discharge in age group 30 to 39 are smear 
positive whereas 30% of women in age group are smear positive.  
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Figure 6: Age distribution of symptomatic and infection positive cases 
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Organism analysis by Age Group 
 
Table 5 - Distribution of individual infections in the age groups 
Age 
Group 
Bacterial 
Vaginosis 
Candida Trichomonas Gonorrhoea Aerobic Vaginitis 
Count Percent Count Percent Count Percent Count Percent Count Percent 
10-19 2 4.2 % 3 8.8 % 0 0 % 0 0 % 2 9.1 % 
20-29 24 50 % 10 29.4 % 15 46.9 % 5 62.5 % 12 54.5 % 
30-39 3 6.3 % 1 2.9 % 2 6.3 % 1 12.5 % 2 9.1 % 
40-49 10 20.8 % 13 38.2 % 5 15.6 % 0 0 % 3 13.6 % 
50-59 4 8.3 % 5 14.7 % 5 15.6 % 2 25 % 3 13.6 % 
60-69 5 10.4 % 2 5.9 % 5 15.6 % 0 0 % 0 0 % 
Total 48  34  32  8  22  
 
Inference  
 Prevalence of white discharge though low in age group 30 to 39, 75% of 
these patients harbor infection. 
 Prevalence of white discharge is high in age group 20 to 29, and 59% of 
these patients harbor infection. 
 Prevalence of infection in age group 60 to 69 also is high -58.6% next only 
to age group 20 to 29 
 Of the 6 cases positive for infections in age group 20 to 29, 50%, (3) 
belonged to candida group. 
 Of the 48 patients positive for Bacterial Vaginosis, 50% belonged to 20 to 
29 age group. 
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 Of the 8 patients positive for gonorrhoea, 62.5% belonged to age group 20 to 
29  
 Of the 34 patients positive for candida 38.2%patients belonged to age group 
40 to 49 
 Of the 32 patients positive for trichomonas, 46.9% patients belong to age 
group 20 to 29% 
 Of the 22 patients positive for Aerobic Vaginitis 54.5% belong to age group 
20 to 29 
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 Category Distribution 
 
Table 6 - Distribution of symptomatic and infection positive cases in categories studied 
Category Number of 
Patients in the 
Category 
Percentage of 
Patients in the 
Category 
Number of 
Infected Patients 
in the Category 
Percentage of 
Infected patients in 
the Category 
1 20 8.6 % 6 30 % 
2 95 40.9 % 58 61.1 % 
3 69 29.7 % 38 55.1 % 
4 48 20.7 % 26 54.2 % 
 Total 232  128  
 
Inference 
 
 Of the patients with complaints of white discharge, maximum, belonged to 
the category of  reproductive age women comprising 95 patients-40.9% 
 Also 61.1% of patients with infections also belonged to this group. 
 Prevalence of infection in perimenopausal and post menopausal age group 
are almost similar, 55.1% and 54.2% respectively. 
 Only 30% of patients in pubertal group with complaints of white discharge 
were harbouring infections. 
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Figure 8: Distribution of symptomatic and infection positive cases in categories 
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Organism Analysis by Category 
 
Table 7 - Distribution of individual infections in the categories studied 
Category 
Bacterial 
Vaginosis 
Candida Trichomonas Gonorrhoea Aerobic Vaginitis 
Count Percent Count Percent Count Percent Count Percent Count Percent 
1 2 4.2 % 3 8.8 % 0 0 % 0 0 % 2 9.1 % 
2 27 56.3 % 11 32.4% 17 53.1 % 6 75 % 14 63.6 % 
3 11 22.9 % 17 50 % 8 25 % 1 12.5 % 5 22.7 % 
4 8 16.7 % 3 8.8 % 7 21.9 % 1 12.5 % 1 4.5 % 
Total 48  34  32  8  22  
 
 
Table 8: Statistical Analysis of individual infections in the categories 
Organism Chi Square Value P Value 
Bacterial Vaginosis 6.275 0.09 
Candida 8.929 0.03 (Significant) 
Trichomonas 4.859 0.183 
Gonorrhoea 4.157 0.295 
Aerobic Vaginitis 6.575 0.089 
 
 
Inference 
 Maximum prevalence of Bacterial Vaginosis in reproductive age category. 
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 Maximum prevalence of candida is in perimenopausal age group, 
association of Candida with perimenopausal age group is statistically 
significant. 
 Maximum prevalence of Trichomonas Vaginitis is in reproductive age 
category, 53.1 
 Maximum prevalence of gonorrhoea is in reproductive age category, 75% 
 Maximum prevalence of Aerobic Vaginitis is also in reproductive age group. 
 Prevalence of Bacterial Vaginosis Trichomonas Vaginitis, and gonorrhoea 
are almost equal in perimenopausal and postmenopausal categories whereas 
prevalence of candida and Aerobic Vaginitis is high in perimenopausal 
category 50% vs. 8.8% and 22.7% vs. 4.5%  
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Figure 9: Distribution of individual infections in the categories 
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 Marital Status Distribution 
 
Table 9: Distribution of infection positive cases by Marital Status 
Marital Status Number of 
Patients in the 
Marital Status 
Percentage of 
Patients in the 
Marital Status 
Number of 
Infected Patients 
in the Status 
Percentage of 
Infected patients in 
the Status 
Married 212 91.4 % 122 95.3 % 
Unmarried 20 8.6 % 6 4.7 % 
 Total 232  128  
 
Chi Square Value = 5.607 
P Value = 0.01788 
Inference 
 Of the 128 patients who are positive for infections, 95.3% i.e. 122 patients 
belonged to married group.  
 P value is < 0.05 - statistically significant. 
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5.6 Organism Analysis by Marital Status 
 
Table 11: Distribution of individual infections by Marital Status 
Marital 
Status 
Bacterial 
Vaginosis 
Candida Trichomonas Gonorrhoea Aerobic Vaginitis 
Count Percent Count Percent Count Percent Count Percent Count Percent 
Married 46 95.8 % 31 91.2 % 32 100 % 8 100 % 20 90.9 % 
Unmarried 2 4.2 % 3 8.8 % 0 0 % 0 0 % 2 9.1 % 
Total 48  34  32  8  22  
 
Inference 
 All infections Bacterial Vaginosis, candida, Trichomonas, gonorrhoea and 
Aerobic Vaginitis have increased prevalence in married group. 
 
Figure 10: Distribution of individual infections by Marital Status 
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Pruritus Distribution 
 
Table 12: association of infections with Pruritus 
Pruritus Number of 
Patients 
Percentage of 
Patients 
Number of 
Infected Patients 
Percentage of 
Infected patients 
With 72 31 % 49 68 % 
Without 160 69 % 23 32 % 
 Total 232  72  
 
Chi Square Value = 66.85 
P < 0.0000001 – statistically significant 
Inference 
 Of the 72 patients (31% of 232 patients with white discharge) with pruritus 
49 patients (68%) are positive for infections. 
 P value <0.05 statistically significant 
 
Figure 11: association of infections with  Pruritus 
  
72 
160 
49 
23 
0 
20 
40 
60 
80 
100 
120 
140 
160 
180 
With Pruritus Without Pruritus 
N
u
m
b
e
r 
o
f 
P
at
ie
n
ts
 
Pruritus Status 
Pruritus Distribution 
Number of Patients 
Number of Infected Patients 
 
68 
Organism Analysis for Patients with Pruritus by Category 
 
Table 13: Distribution of individual infections in patients with Pruritus 
Category 
Bacterial 
Vaginosis 
Candida Trichomonas Gonorrhoea Aerobic Vaginitis 
Count Percent Count Percent Count Percent Count Percent Count Percent 
1 0 0 % 3 10.7 % 0 0 % 0 0 % 0 0 % 
2 4 57.1 % 8 28.6 % 8 57.1 % 0 0 % 0 0 % 
3 3 42.9 % 14 50 % 4 28.6 % 0 0 % 0 0 % 
4 0 0 % 3 10.7 % 2 14.3 % 0 0 % 0 0 % 
Total 7  28  14  0  0  
 
P value for candida – 0.01 
Inference 
 No patients with gonorrhoea and Aerobic Vaginitis have associated pruritus. 
 Of the 49 patients with pruritus, 28  (57.1%)are positive candida 
 14.2% of infection positive patients and 28% of infection positive patients 
have associated pruritus.  
 
Figure 12: Distribution of individual infections in patients with Pruritus 
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 UTI Distribution 
 
Table 14: association of infections  with Symptoms of UTI 
UTI Symptoms Number of 
Patients 
Percentage of 
Patients 
Number of 
Infected Patients 
Percentage of 
Infected patients 
With 24 10.3 % 19 14.8 % 
Without 208 89.7 % 109 85.2 % 
 Total 232  128  
 
Chi Square Value = 6.231 
P Value = 0.013 
Inference 
 Of the 232 patients with complaints of white discharge 24 have associated 
dysuria. 
 Of the 24 patients with associated dysuria, 79.1% are positive for infections. 
 P value is statistically significant  
 
Figure 13: Distribution of infected patients with Symptoms of UTI 
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 Organism Analysis for UTI Symptoms by Category 
 
Table 15: Distribution of infection in patients with UTI Symptoms 
Category 
Bacterial 
Vaginosis 
Candida Trichomonas Gonorrhoea Aerobic Vaginitis 
Count Percent Count Percent Count Percent Count Percent Count Percent 
1 0 0 % 1 11.1 % 0 0 % 0 0 % 0 0 % 
2 3 50 % 3 33.3 % 2 66.7 % 0 0 % 2 66.7 % 
3 1 16.7 % 3 33.3 % 1 33.3 % 0 0 % 1 33.3 % 
4 2 33.3 % 2 22.2 % 0 0 % 0 0 % 0 0 % 
Total 6  9  3  0  3  
Inference 
 No patient with dysuria is positive for gonorrhoea 
 37.5% of patients with dysuria are positive for candida 
 25% of patients with dysuria are positive for Bacterial Vaginosis. 
 Trichomonas Vaginitis and Aerobic Vaginitis are positive in 12.5% of 
patients with associated dysuria. 
 
Figure 14: Distribution of infection in patients with UTI Symptoms 
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Diabetes Distribution 
 
Table 16: association of infections  with  Diabetes 
Diabetes Number of 
Patients 
Percentage of 
Patients 
Number of 
Infected Patients 
Percentage of 
Infected patients 
With 17 7% 12 9.3% 
Without 215 93% 116 90.7% 
 Total 232  128  
 
Chi Square Value = 1.763 
P Value = 0.184 
Inference 
 Of the 17 patients who are positive with h/o diabetes mellitus, 12 patients 
70.5% are positive for infections whereas only 53.9% of patients without 
diabetes are positive for infections. 
 P value > 0.05, hence statistically significant. 
 
Figure 15: association of infections with  Diabetes 
17 
215 
12 
109 
0 
50 
100 
150 
200 
250 
With Without 
N
u
m
b
e
r 
o
f 
P
at
ie
n
ts
 
Diabetes 
Diabetes Distribution 
Number of Patients 
Number of Infected Patients 
 
72 
Organism Analysis for Diabetes by Category 
 
Table 17: Distribution of individual infection in patients with risk of Diabetes 
Category 
Bacterial 
Vaginosis 
Candida Trichomonas Gonorrhoea Aerobic Vaginitis 
Count Percent Count Percent Count Percent Count Percent Count Percent 
1 0  0  0  0  0  
2 2  2  0  0  0  
3 0  5  0  0  1  
4 1  3  0  0  0  
Total 3  10  0  0  1  
P value for candida-0.001 
Inference 
Of the total 14 cases with diabetes, 10 are positive for Candida i.e. 71.4%. 
 
 
Figure 16: Distribution of individual infection in patients with risk of Diabetes 
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 Mixed infection Analysis 
 
Table 18: Distribution of patients with multiple infections by Category 
Category BV + 
CAND 
BV 
+ TV 
BV + 
GON 
BV + 
AV 
CAND 
+ TV 
CAND 
+ GON 
CAND 
+ AV 
TV+ 
GON 
TV + 
AV 
GON + 
AV 
BV + CAND 
+ TV 
1 0 0 0 0 0 0 0 0 0 0 0 
2 4 8 0 7 1 0 0 0 0 0 1 
3 0 2 0 2 0 0 0 0 0 0 0 
4 0 0 0 0 0 0 0 0 0 0 0 
Total 4 10 0 9 1 0 0 0 0 0 1 
Inference 
 Mixed infections are seen in 24 of total 128 infection positive patients 
(18.75%). 
 Of this 41.6% is due the Bacterial Vaginosis and Trichomonas Vaginitis and 
37.5% due to Bacterial Vaginosis and Aerobic Vaginitis. 
 Mixed infection by Bacterial Vaginosis, Trichomonas Vaginitis and Aerobic 
Vaginitis is seen in one case. (4.1%) 
 
Figure 17: Distribution of patients with multiple infections by Category 
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 Aerobic Vaginitis Analysis by Age Group 
 
Table 19: Distribution of patients with Aerobic Vaginitis by Age Group 
Age Group Aerobic Vaginitis 
Count Percent 
10-19 2 9.1 % 
20-29 12 54.5 % 
30-39 2 9.1 % 
40-49 3 13.6 % 
50-59 3 13.6 % 
60-69 0 0 % 
Total 22  
 
Inference 
Of the 22 patients diagnosed as Aerobic Vaginitis, 12 belonged to the age 
group 20 to 29 (54.5%) 
 
Figure 18: Distribution of patients with Aerobic Vaginitis by Age Group 
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 Aerobic Vaginitis Analysis by Category 
 
Table 20: Distribution of patients with Aerobic Vaginitis by category 
Category 
Aerobic Vaginitis 
Count Percent 
1 2 9.1 % 
2 14 63.6 % 
3 5 22.7% 
4 1 4.5 % 
Total 22  
Inference 
Of the 22 patients with Aerobic Vaginitis, 14 belonged to reproductive age 
category (63.6%) 
 
 
Figure 19: Distribution of patients with Aerobic Vaginitis by Category 
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 Aerobic Vaginitis Analysis by Marital Status 
 
Table 21: association of Aerobic Vaginitis with Marital Status 
Marital Status 
Aerobic Vaginitis 
Count Percent 
Married 20 90.9 % 
Unmarried 2 9.1 % 
Total 22  
 
Chi Square Value = 1.153 
P Value = 0.28 (not significant) 
Inference 
90.9% of patients with Aerobic Vaginitis belong to married group 
 
 
Figure 20 association of Aerobic Vaginitis with Marital Status 
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 Aerobic Vaginitis in Patients with Pruritus by Category 
 
Table 22: association of Aerobic Vaginitis s with Pruritus 
Pruritus Positive Negative 
With 0 72 
Without 22 138 
Total 22 210 
 
Inference 
No case of Aerobic Vaginitis complained of associated pruritus. 
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 Aerobic Vaginitis in Patients with UTI Symptoms by Category 
 
Table 23: association of Aerobic Vaginitis with UTI Symptoms 
UTI Symptoms Positive Negative 
With 3 16 
Without 19 180 
Total 22 196 
 
Chi Square Value = 0.7447 
P Value = 0.3882 
Inference 
 3 out of 22 patients with Aerobic Vaginitis have associated UTI symptoms 
(13.6%) 
 P value is statistically not significant 
 
 
Figure 21: Distribution of Aerobic Vaginitis in patients with UTI Symptoms 
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 Aerobic Vaginitis in Patients with Diabetes by Category 
 
Table 24: association of Aerobic Vaginitis with Diabetes 
Diabetes Positive Negative 
With 1 11 
Without 21 93 
Total 22 104 
 
Chi Square Value = 0.76 
P Value = 0.3813 
Inference 
 One of 22 patients with Aerobic Vaginitis is positive for diabetes mellitus 
(4%) 
 P value is not significant 
 
 
Figure 22: Distribution of Aerobic Vaginitis in patients with Diabetes 
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6.  SUMMARY 
 
 55.1% of patients with white discharge are positive for infections. 
 35.8% of patients with white discharge belong to age group 20 to 29. 
 5.2% of patients with white discharge belong to age group 30 to 39. 
 38.2% of patients with infections belong to age group 20 to 29. 
 4% of patients with infections belong to age group 10 to19. 
 Maximum prevalence of Bacterial Vaginosis, Trichomonas Vaginitis, 
gonorrhoea, Aerobic Vaginitis is seen in age group 20 to 29. 
 Maximum prevalence is seen in patients aged 40 to 49. 
 No case of gonorrhoea in age group 40 to 49 and 60 to 69. 
 No case of Aerobic Vaginitis in age group 60 to 69. 
 40.9% of patients with white discharge belong to reproductive age category. 
 45.3% of patients positive for infections belong to reproductive age 
category. 
 4% of patients positive for infections belong to pubertal age category. 
 30% of patients in pubertal age category are positive infections. 
 Prevalence of Bacterial vaginosis, Trichomonas Vaginitis, gonorrhoea and 
Aerobic Vaginitis infections is maximum in reproductive age group 56.3%, 
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53.1%, 75%, and 63.6% whereas prevalence of candidal vaginitis is 
maximum in perimenopausal category. 
 No case of Trichomonas Vaginitis and gonorrhoea is seen in pubertal age 
group. 
 91.4% of patients with white discharge belong to married group. 
 95.3% of patients with infections belong to married group. 
 No case of Trichomonas Vaginitis and gonorrhoea is seen in unmarried 
group. 
 Presence of associated pruritus is significantly associated with infection 
positive cases. 
 Presence of pruritus is significantly associated with Candida. 
 Presence of UTI symptoms is significantly associated with infections. 
 Individual organism association with UTI symptoms is not significant. 
 Diabetes is not significantly associated with infection positive cases but it is 
significantly associated with Candida. 
 Maximum prevalence of Aerobic Vaginitis is seen in age group 20 to 29, 
reproductive age category, married group. 
 Apart from white discharge, Aerobic Vaginitis patients have presented with 
UTI symptoms yet it is not statistically significant. Also association of 
diabetes to Aerobic Vaginitis is also not significant.   
 
82 
7. DISCUSSION 
 
 Prevalence of infections with white discharge in our study is 55.1% whereas 
in studies by Kulkarni et al
1
, RD Catterall et al
10
, Arsenilo Spinillo et al
8
, 
prevalence of infections in patients with white discharge is around 30% - 
this may be due to the difference in the population under study, and most of 
these studies looking for prevalence are community based whereas our study 
is hospital based. 
   Prevalence of gonorrhoea in our study sample is low – 6% which is similar 
to the study conducted by Abauleth et al
11
 in Cocody University Hospital, 
Abidjan – 2.9% and study by Faye-ketteYH10 et al in Ivory coast whereas in 
studies conducted by Mirza NB et al
9
 at Nairobi, Kenya and Lobb et al
12
 at 
Mauritania, the prevalence of gonorrhoea is high 26% and 64.4% 
respectively. 
 There is no significant difference in the prevalence of Bacterial Vaginosis, 
candida and Trichomonas Vaginitis from the previous studies done 
elsewhere. 
 Prevalence of infections is high in reproductive age, sexually active women 
similar to study by Arsenio Spinillo
3
. 
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 Like in studies by Kulkarni et al1 and Parashari et al3, prevalence of infection 
is high in married group in our study. 
 Prevalence of mixed infection in our study is 18.4% whereas in study by 
Mirza NB
9
, it is 23%. But in study by RD Catteral
10
 it is high – 74% 
 Study by Donders et al14 on Aerobic Vaginitis has shown that pruritus can be 
one of the complaints of patients with Aerobic Vaginitis, but in our study no 
patient with Aerobic Vaginitis has associated pruritus. 
 Study by Donders et al15 has also shown that mixed infection by Bacterial 
Vaginosis and Aerobic Vaginitis is common which is also seen in our study 
37.5% 
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8. CONCLUSION 
 
 Prevalence of Bacterial Vaginosis, gonorrhoea, Trichomonas Vaginitis and 
Aerobic Vaginitis is high in age group 20 to 29. 
 Prevalence of Bacterial Vaginosis, Trichomonas Vaginitis, gonorrhoea and 
Aerobic Vaginitis is high in sexually active reproductive age women. 
 Prevalence of candida is high in 40 to 49 age group. 
 Prevalence of candida is high in perimenopausal women in whom the 
prevalence of diabetes is also high. 
 Prevalence of infection in pubertal category is only 30%, and in 
perimenopausal and post menopausal category is around 50 %. Hence in 
these patients with white discharge proper examination and evaluation must 
be carried out to rule out non infectious causes of white discharge before 
initiating empirical antibiotic therapy. 
 Prevalence of mixed infection is common. 
 All 5 infections under study causing white discharge have high prevalence in 
married group. This can imply that sexual exposure is a risk factor for 
vaginal infections along with other factors like menstruation, obstetric 
trauma. 
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 If associated symptoms like pruritus and UTI symptoms are present, the 
probability of them harbouring infections is also high. 
 Presence of pruritus is significantly associated with candida infection. 
 UTI symptoms prevalence is high in Bacterial Vaginosis patients but it is not 
statistically significant. 
 Presence of diabetes is significantly associated with candidal infection. 
 Aerobic vaginitis 
o High prevalence in age group 20 to 29 
o High prevalence in sexually active reproductive age women 
o High prevalence in married women 
o May be associated with UTI symptoms- not statistically significant 
o Our study reveals no association between pruritus and Aerobic 
Vaginitis 
o No statistically significant association between presence of diabetes 
and Aerobic Vaginitis. 
o Mixed infection with Bacterial Vaginosis is common. 
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ANNEXURE II - MASTER CHART 
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1 Seetha lakshmi 23 2 2 1 2 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
2 Asha 46 4 3 1 2 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
3 Nithya 25 2 2 1 2 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
4 Vidhya 26 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
5 Anitha 21 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
6 Vasanthi 49 4 3 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
7 Radhika 46 4 3 1 2 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
8 Fathima 21 2 2 1 2 0 0 0 1 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 
9 lakshmi 60 6 4 1 6 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
10 Vinitha 26 2 2 1 2 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
11 Devi 27 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
12 Gowri 48 4 3 1 3 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
13 Kuppammal 58 5 4 1 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
14 Nalini 31 3 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
15 Saraswathy 50 5 3 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
16 Sasikala 51 5 3 1 2 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
17 Saritha 25 2 2 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
18 Manonmani 49 4 3 1 4 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
19 Ezhilarasi 26 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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20 Sivasankari 45 4 3 1 3 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
21 Priscella 22 2 2 1 2 0 0 0 1 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 
22 Divyadarshini 13 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
23 Sathyajothi 24 2 2 1 1 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
24 manjula 47 4 3 1 3 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
25 Sheela 48 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
26 Bhuvaneshwari 61 6 4 1 4 1 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
27 Devi 27 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
28 manjula 45 4 3 1 2 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
29 Senthamarai 49 4 3 1 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
30 Amudha 59 5 4 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
31 Noorjahan 23 2 2 1 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
32 Suganya 50 5 3 1 2 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
33 Ezhilarasi 16 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
34 Pramila 51 5 3 1 3 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
35 Sengammal 57 5 4 1 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
36 Jeya 21 2 2 1 1 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
37 Devi 58 5 4 1 3 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
38 Maheshwari 28 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
39 Rani 65 6 4 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
40 Dhanalakshmi 29 2 2 1 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
41 Munyammal 22 2 2 1 1 0 1 1 1 1 1 0 0 0 1 0 0 0 0 0 0 0 0 0 
42 Kavitha 47 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
43 Sujatha 34 3 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
44 Salarathi 67 6 4 1 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
45 Sasirekha 49 4 3 1 4 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
46 Sangeetha 32 3 2 1 1 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
47 Kanchana 24 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
48 Lalitha 25 2 2 1 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
49 Saranya 16 1 1 0 9 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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50 Durga 48 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
51 Latha 26 2 2 1 1 1 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 0 0 0 
52 Vanitha 15 1 1 0 9 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
53 Mahalakshmi 22 2 2 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
54 RAni 45 4 3 1 2 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
55 Maheshwari 21 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
56 Geetha 26 2 2 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
57 Alifathima 25 2 2 1 1 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
58 Mutamilselvi 69 6 4 1 3 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
59 Elakiya 16 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
60 Sivagami 23 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
61 Kavitha 16 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
62 Meena 46 4 3 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
63 Padmavathy 24 2 2 1 2 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
64 Jayalalitha 21 2 2 1 2 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
65 Vasanthi 51 5 3 1 2 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
66 Ganga 46 4 3 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
67 devagi 63 6 4 1 3 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
68 Sindhu 16 1 1 0 9 0 1 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 
69 Valliammal 59 5 4 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
70 Kumari 28 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
71 Devika 30 3 2 1 1 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
72 Chitra devi 31 3 2 1 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
73 Tamilarasi 24 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
74 Ganga 61 6 4 1 2 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
75 Jothilakshmi 48 4 3 1 2 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
76 Nagammal 59 5 4 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
77 Mariammal 24 2 2 1 1 0 1 1 1 1 1 0 0 0 1 0 0 1 0 0 0 0 0 0 
78 Sarala 47 4 3 1 2 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
79 Girija 26 2 2 1 1 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
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80 Dhanalakshmi 65 6 4 1 4 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
81 Sujatha 49 4 3 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
82 Gomathy 28 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
83 Kanmani 45 4 3 1 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
84 Abitha 46 4 3 1 4 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
85 Kanchana 51 5 3 1 5 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
86 Sheeba 50 5 3 1 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
87 Ramya 21 2 2 1 3 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
88 Barani 24 2 2 1 2 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
89 Anitha 25 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
90 Sarala 69 6 4 1 3 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
91 karpagam 68 6 4 1 3 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
92 Girija 24 2 2 1 1 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
93 Nadhiya 23 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
94 Pazhaniammal 65 6 4 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
95 Narmadha 33 3 2 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
96 Visalakshi 28 2 2 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
97 Vijaya 27 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
98 Kavitha 68 6 4 1 3 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
99 Dillirani 49 4 3 1 2 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
100 Mohana 21 2 2 1 2 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
101 Nagarani 23 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
102 SAranya 47 4 3 1 4 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
103 Sarala 48 4 3 1 4 0 0 0 1 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 
104 Kasthuri 65 6 4 1 3 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
105 Lakshmi 25 2 2 1 1 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
106 Mubarack 60 6 4 1 2 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
107 Chithra 29 2 2 1 2 0 0 0 1 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 
108 Kanimozhi 47 4 3 1 2 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
109 Hemalatha 45 4 3 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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110 Jeyanthi 46 4 3 1 3 1 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
111 Annalakshmi 33 3 2 1 2 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
112 Durga devi 31 3 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
113  selvi ammal 28 2 2 1 2 0 1 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 
114 Pushpa mary 58 5 4 1 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
115 Jansi rani 49 4 3 1 3 1 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
116 Nagammal 27 2 2 1 3 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
117 Asifa 62 6 4 1 4 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
118 Jasleena banu 20 2 2 1 4 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
119 saroja 45 4 3 1 3 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
120 Solai 60 6 4 1 4 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
121 Deepa 48 4 3 1 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
122 Anitha 47 4 3 1 4 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
123 Jebaselvi 21 2 2 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
124 Kavitha 27 2 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
125 Sasikala 58 5 4 1 2 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
126 Sangeetha 24 2 2 1 1 0 0 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 
127 Seema 31 3 2 1 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
128 Arulkumari 51 5 3 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
129 Govindammal 65 6 4 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
130 Neelavathi 28 2 2 1 2 0 1 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 
131 Sundari 50 5 3 1 3 0 1 0 1 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 
132 Lavanya 15 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
133 Radha 26 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
134 priya 14 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
135 Selvi 48 4 3 1 3 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
136 Sathya 49 4 3 1 3 1 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
137 Bagyalakshmi 24 2 2 1 2 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
138 Bindu 22 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
139 Sheela 63 6 4 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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140 Sedhulakshmi 50 5 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
141 Kavitha 21 2 2 1 2 0 0 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 
142 Asha 65 6 4 1 4 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
143 Hemavathy 68 6 4 1 3 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
144 Sasikala 27 2 2 1 3 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
145 Manimala 65 6 4 1 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
146 hema 50 5 3 1 3 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
147 Govindammal 26 2 2 1 2 0 0 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 
148 Kantha 47 4 3 1 3 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
149 Seetha  48 4 3 1 4 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
150 Ganga 29 2 2 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
151 sunmathi 62 6 4 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
152 Ranjitha 49 4 3 1 2 0 0 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 
153 Priya 26 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
154 Anandhi 49 4 3 1 3 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
155 Stellamary 48 4 3 1 4 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
156 Kalaiarasi 50 5 3 1 4 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
157 Suganya 25 2 2 1 2 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
158 Barathi 14 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
159 latha 61 6 4 1 3 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
160 Maheshwari 51 5 3 1 3 0 0 1 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
161 Malathy 34 3 2 1 2 0 0 0 1 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 
162 Chellammal 59 5 4 1 2 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
163 Dairu nishA 58 5 3 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
164 Sangeetha 35 3 2 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
165 mala 31 3 2 1 1 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
166 Gomathy 57 5 4 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
167 chitra 46 4 3 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
168 Muneeswari 28 2 2 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
169 Ambika 59 5 4 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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170 Geetha 29 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
171 Ponmozhi 26 2 2 1 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
172 Kasthuri 61 6 4 1 3 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
173 nagarani 60 6 4 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
174 Kuppammal 68 6 4 1 4 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
175 kamatchi 46 4 3 1 3 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
176 Sumitha 15 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
177 Kanmani 16 1 1 0 9 1 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
178 Nandhini 25 2 2 1 2 0 1 0 1 1 1 1 0 0 1 1 0 0 1 0 0 0 0 0 
179 Renuka 51 5 3 1 3 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
180 Munishmary 60 6 4 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
181 Pavithra 24 2 2 1 2 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
182 Radha 50 5 3 1 2 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
183 Poongothai 56 5 4 1 1 1 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
184 Muniyammal 57 5 4 1 2 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
185 Shameela 22 2 2 1 2 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
186 Devi 49 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
187 Radhika 47 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
188 Nirosha 16 1 1 0 9 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
189 Saritha 21 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
190 prema 53 5 4 1 3 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
191 Andal 46 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
192 Priyanka 15 1 1 0 9 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
193 kamala 20 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
194 kanchana 61 6 4 1 3 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
195 Barathy 59 5 4 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
196 Kala 45 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
197 Saritha 24 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
198 rani ammal 49 4 3 1 3 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
199 Sangeetha 25 2 2 1 3 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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200 manjula 23 2 2 1 2 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
201 kalavathy 46 4 3 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
202 thangam 21 2 2 1 2 0 0 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 
203 seetha 20 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
204 priya 13 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
205 Rathinam 57 5 4 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
206 chithra 29 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
207 ganga 48 4 3 1 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
208 radha 26 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
209 vennila 14 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
210 porkalai 23 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
211 banu 16 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
212 senbagam 48 4 3 1 2 1 1 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 
213 kavitha 22 2 2 1 2 0 0 0 1 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 
214 rajathi 26 2 2 1 2 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
215 ambujam 57 5 4 1 3 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 
216 nayagi 46 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
217 nisha 24 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
218 priyanka 15 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
219 rajammal 52 5 3 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
220 kumudha 21 2 2 1 2 0 1 0 1 1 0 1 0 0 0 1 0 0 0 0 0 0 0 0 
221 sumathi 51 5 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
222 mary 27 2 2 1 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
223 kaveri 15 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
224 vijaya 26 2 2 1 2 1 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
225 selvakani 48 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
226 Saroja 59 5 4 1 3 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
227 arumai kani 24 2 2 1 2 1 0 0 1 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 
228 vanitha 22 2 2 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
229 vadivammal 60 6 4 1 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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230 sathya 16 1 1 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
231 umayal 48 4 3 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
232 Pazhaniyammal 56 5 4 1 3 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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ANNEXURE III - KEY TO MASTER CHART 
AGE GROUP 
 1 – 10 to 19 years 
 2 – 20 to 29 years 
 3 – 30 to 39 years 
4 – 40 to 49 years 
5 – 50 to 59 years 
6 – 60 to 69 years 
CATEGORY 
 1 – Attained Menarche, Less than 18 years, No sexual exposure 
 2 – 18 to 35 years with sexual activity 
 3 – Perimenopausal age group, 45 to 52 years 
 4 – Post menopausal women, 1 year after the cessation of menses 
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ORGANISMS 
 BV – Bacterial Vaginosis 
CV – Candida 
TV – Trichomonas Vaginitis 
G – Gonorrhoea 
AV – Aerobic Vaginitis 
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ANNEXURE IV – PROFORMA 
 
NAME     : 
AGE      : 
ADDRESS     : 
OP NO     : 
DATE OF VISIT    : 
HISTORY OF PRESENTING COMPLAINT: 
 DURATION   : 
 QUANTITY    : 
COLOUR    : 
SMELL    : 
ASSOCIATED SYMPTOMS  : 
COITAL HISTORY   : 
 DURATION OF SEXUALLY ACTIVE LIFE: 
 LAST COITAL HISTORY : 
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 HISTORY OF SIMILAR COMPLAINT IN THE PARTNER: 
  IF YES, DETAILS : 
OBSTETRIC HISTORY   : 
USE OF IUD    : 
HISTORY OF DIABETES  : 
OTHER MEDICAL ILLNESS  : 
HISTORY OF DRUG INTAKE : 
HISTORY OF RECENT SURGERIES: 
GENERAL EXAMINATION  : 
VITALS     : 
SYSTEMIC EXAMINATION  : 
  CARDIOVASCULAR SYSTEM : 
  RESPIRATORY SYSTEM  : 
  CENTRAL NERVOUS SYSTEM : 
  ABDOMINAL EXAMINATION : 
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LOCAL EXAMINATION  : 
SPECULUM EXAMINATION  : 
PELVIC EXAMINATION  : 
PAP SMEAR    : 
VAGINAL DISCHARGE FOR MICROBIAL STUDY: 
RANDOM BLOOD SUGAR  : 
 
Signature of Investigator:    Signature of Guide: 
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ANNEXURE V – LETTER OF CONSENT 
சுய ஒப்புதல் படிவம் 
ஆய்வு செய்யப்படும் தலைப்பு : An epidemiological analysis of abnormal vaginal 
discharge in patients attending gynaec OP, KMCH 
Department of Obstetrics and Gynaecology, KMCH 
பங்கு சபறுபவரின் சபயர் : 
பங்கு சபறுபவரின் வயது :   பங்கு சபறுபவரின் எண் : 
மேமே குறிப்பிட்டுள்ள ேருத்துவ ஆய்வின் விவரங்கள் எனக்கு விளக்கப்பட்டது.  
நான் இவ்வாய்வில் தன்னிச்சையாக பங்மகற்கிமறன்.  எந்த காரணத்தினாமோ எந்த ைட்ட 
ைிக்கலுக்கும் உட்படாேல் நான் இவ்வாய்வில் இருந்து விேகிக் ககாள்ளல்ோம் என்றும் 
அறிந்து ககாண்மடன். 
இந்த ஆய்வு ைம்பந்தோகமவா, இசத ைார்ந்து மேலும் ஆய்வு மேற்ககாள்ளும் 
மபாதும் இந்த ஆய்வில் பங்குகபறும் ேருத்துவர் என்னுசடய ேருத்துவ அறிக்சககசள 
பார்ப்பதற்கு என் அனுேதி மதசவயில்சே என அறிந்து ககாள்கிமறன்.  இந்த ஆய்வின் 
மூேம் கிசடக்கும் தகவசேமயா, முடிசவமயா பயன்படுத்திக் ககாள்ள 
ேறுக்கோட்மடன். 
இந்த ஆய்வில் பங்கு ககாள்ள ஒப்புக் ககாள்கிமறன்.  இந்த ஆய்சவ 
மேற்ககாள்ளும் ேருத்துவ அணிக்கு உண்சேயுடன் இருப்மபன் என்றும் 
உறுதியளிக்கிமறன். 
 
பங்மகற்பவரின் சககயாப்பம் 
இடம் : 
மததி : 
பங்மகற்பவரின் கபயர் ேற்றும் விோைம் : 
ஆய்வாளரின் சககயாப்பம் : 
இடம் :       மததி : 
ைாட்ைியாளரின் சககயாப்பம் 
இடம் : 
மததி : 
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ANNEXURE VI - GLOSSARY 
 
Abbreviation Description 
CDC Centre for Disease Control 
DM Diabetes Mellitus 
E. coli Escherichia Coli 
ELISA Enzyme Linked Immuno Sorbent Assay 
HIV Human Immuno-deficiency Virus 
HPV Human Papilloma Virus 
IUCD Intra Uterine Contraceptive Device 
KOH Potassium Hydroxide 
OP Out Patient 
PID Pelvic Inflammatory Disease 
PV Per Vaginal Examination 
UTI Urinary Tract Infection 
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ANNEXURE VII – ETHICAL COMMITTEE APPROVAL 
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ANNEXURE VIII – PLAGIARISM REPORT 
 
 
